Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
999.9 ILa | +0.77% | +7.52% | +115.91% |
Apr. 01 | InterCure Ltd. Provides Earnings Guidance for the Second Half and Full Year of 2023 | CI |
Mar. 22 | InterCure Ltd. Expects to Launch Its First Products in Germany in the Coming Months | CI |
Sales 2021 | 219.68 83.63K | Sales 2022 | 388.68 148K | Capitalization | 551M 210B |
---|---|---|---|---|---|
Net income 2021 | 4M 1.52B | Net income 2022 | 44M 16.75B | EV / Sales 2021 | 3,844,919 x |
Net cash position 2021 | 87.64M 33.36B | Net Debt 2022 | 22.37M 8.51B | EV / Sales 2022 | 1,473,908 x |
P/E ratio 2021 |
207
x | P/E ratio 2022 |
12.2
x | Employees | 370 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 64.2% |
Latest transcript on InterCure Ltd.
1 day | +0.77% | ||
1 week | +7.52% | ||
Current month | +1.31% | ||
1 month | +8.89% | ||
3 months | +109.45% | ||
6 months | +126.22% | ||
Current year | +115.91% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 53 | 18-09-30 | |
Amos Cohen
DFI | Director of Finance/CFO | 45 | 20-02-29 |
Boaz Lahav
SAM | Sales & Marketing | - | 22-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ehud Barak
CHM | Chairman | 81 | 18-08-31 |
Chief Executive Officer | 53 | 18-09-30 | |
Director/Board Member | 62 | 20-10-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
13.29% | 3 M€ | -35.65% | - | |
0.13% | 13 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 999.9 | +0.77% | 161,024 |
24-04-24 | 992.3 | +5.01% | 104,493 |
24-04-21 | 945 | +1.61% | 260,483 |
Delayed Quote TEL AVIV STOCK EXCHANGE, April 25, 2024 at 07:24 am EDT
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+115.91% | 119M | |
+31.96% | 272M | |
+33.74% | 261M | |
+49.42% | 194M | |
+44.98% | 131M | |
-28.57% | 121M | |
0.00% | 86.82M | |
+150.00% | 75.33M | |
+1.20% | 55.24M | |
+14.38% | 52.63M |
- Stock Market
- Equities
- INCR Stock